Resolving the Four-Way Ambiguity in Korean What-so Constructions
Japanese/Korean Linguistics · 31.07.2026 · 32 (1)
DOI: 10.5070/j7.67130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese/Korean Linguistics, online erschienen am 31.07.2026. Verfasst von Geonhee Lee. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study investigates how Korean what-so (mwue-l kulehkey ‘what-ACC so’) constructions are disambiguated through prosodic and morphosyntactic cues. Previous studies have shown that these constructions permit three non-canonical interpretations (why-question, wh-exclamative, rhetorical question), in addition to the canonical what-question interpretation. Based on an analysis of naturally occurring speech, we demonstrate that cues to these interpretations are found in both morphosyntax and prosody. Morphosyntactically, topic-marked subjects are incompatible with rhetorical question interpretations, while the presence of an additional accusative-marked object favors wh-exclamatives and why-question readings. Prosodically, wh-question interpretations (what- and why-questions) are associated with rising Intonational Phrase (IP) boundary tones, whereas non-wh-question interpretations (wh-exclamatives and rhetorical questions) exhibit falling IP boundary tones. Overall, these findings demonstrate how Korean employs morphosyntactic marking and prosodic boundary tones to resolve interpretive ambiguity in what-so constructions.
Zitieren
APA
Lee, G. (2026). Resolving the Four-Way Ambiguity in Korean What-so Constructions. Japanese/Korean Linguistics, 32(1). https://doi.org/10.5070/j7.67130
Vancouver
Lee G. Resolving the Four-Way Ambiguity in Korean What-so Constructions. Japanese/Korean Linguistics. 2026;32(1). doi:10.5070/j7.67130
BibTeX
@article{Lee2026,
author = {Lee, Geonhee},
title = {Resolving the Four-Way Ambiguity in Korean What-so Constructions},
journal = {Japanese/Korean Linguistics},
year = {2026},
volume = {32},
number = {1},
doi = {10.5070/j7.67130}
}
EUVIMED